Bio logo
A digital revolution A person-centric approach

GSK, Stevenage

26 November 2024

Advanced Therapies Integrates 2024 Agenda

GSK, Stevenage, 26 November 2024

Discuss cutting-edge research and disruptive innovation in the wide-spread adoption of Advanced Therapies, in this one-day gathering of pharma innovators, regulators, supply chain partners, equipment & technology providers, academia and industry associations, alongside a wide array of government funding bodies and government supported pharma-focused initiatives.


PLEASE NOTE – The timings have not been finalised so maybe subject to change.



Headline Sponsor:

Gold Sponsor:


Silver Sponsors: 


Gold Sponsors

Silver Sponsors

Bronze Sponsors


How are new digital technologies advancing ATMP discovery, development and manufacturing, and what does this mean for regulations?
How is the ATMP sector overcoming challenges to ensure we can develop and deliver affordable and accessible therapies for the people who need them?

Registration & Networking

08:30 – 09:30

Registration and networking

Welcome & Opening Remarks

09:30 – 09:40

Welcome & Opening Remarks


Fireside Chat

09:40 – 10:00

Fireside Chat: For the people who need them

A patient group presentation exploring the patient-perspective on the importance of innovations, new gene therapies, and what ATMPs mean for the people, families and communities we’re developing them for.

Session 1

10:05 – 10:50

Make them better

Digital technologies offer new opportunities to overcome key challenges in ATMP manufacturing, such as quality control, efficiency and sustainability. How is the UK embracing these opportunities to make ATMPs faster and more efficiently?

Networking Coffee Break

10:50 – 11:20

Networking Coffee Break

Session 2

11:20 – 12:05

It’s an upskill battle

Manufacturing ATMPs requires advanced and constantly evolving skills. How can industry and government work together to ensure the UK has the skilled workforce needed for the growth of the ATMP sector?

Session 3

12:10 – 12:55

Hub-ble Bubble

The UK is home to world-class innovation hubs and science parks. How do these hubs support the collaboration and sharing of facilities and expertise required for successful ATMP development?

Networking Lunch

12:55 – 13:55

Networking Lunch

Session 4

13:55 – 14:40

Are we there with rare?

Last year, the government announced a £14 million investment to the UK Rare Disease Research Platform. How is this feeding into the ATMP sector to facilitate the development of new and innovative treatments for people living with rare diseases?

Session 5

14:45 – 15:30

Meet sooner than later with the regulator

Quality assurance, data transparency, and supply chain traceability are vital for regulatory approval. How can new technologies help the ATMP sector meet regulatory guidelines? And how can regulatory guidelines adapt to accommodate ever more innovative technologies?

Session 6

15:35 – 16:05

Investing in our health

We need to get advanced therapies to the people who need them rapidly and cost-effectively. How can we improve the bench to bedside journey to cut costs and improve efficiencies? How can we ensure the UK sees ATMPs as an investment in our health and economy?

Networking Drinks

16:05 – 17:05

Drinks Reception

Gold Sponsors

Silver Sponsors

Bronze Sponsors

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.